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nephrolithiasis.
Background. It is unknown whether stone formers may safely
donate a kidney. Nephrectomy could accelerate stone forma-
tion, or loss of filtration with age. We contrast, here, the course
of stone patients with two versus one kidney.
Methods. One hundred fifteen patients with a single function-
ing kidney were compared with 3151 patients with two kidneys.
Cause of kidney loss was determined, along with stone types,
rates of stone formation, urine stone risk factors, and creatinine
clearance.
Results. Women were 49.6% of the patients with kidney loss,
compared to 33.6% of ordinary stone formers. Obstruction,
stone burden, and infection were the most common reasons
for kidney loss. We found an increased number of struvite and
calcium phosphate stones among single kidney patients. Before
and during treatment, single kidney patients had fewer stones
than ordinary stone formers. Creatinine clearance was lower
in the single kidney patients; rate of loss of kidney function
with age was higher among single kidney males versus two kid-
ney males if all patients are considered. Among males >age
45 years, the difference disappears. Females with one and two
kidneys lost function with age at equivalent rates. Compared
with nonstone formers, male stone formers lose kidney func-
tion with age at an accelerated rate.
Conclusion. Nephrectomy does not worsen stone disease. It
may increase loss of renal function among younger males. The
pattern of renal function loss with age differs between stone
formers and nonstone formers.
Whether or not people who form kidney stones can
safely donate a kidney is at best uncertain. National opin-
ion, as reflected in standard sources [1–3] varies. On the
one hand, routine calcium oxalate stones, the most com-
mon ones, are generally a benign, if painful condition,
that can be controlled by well-established treatments [4];
the same can be said for uric acid stones. Even so, stones
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can lead to renal injury, from obstruction, surgical pro-
cedures, infection, and growth to very large sizes, with
renal tissue injury. For this reason, removing a kidney
could prejudice the health outcomes of stone-forming
people. It is possible that single kidney stone formers
could lose renal function more rapidly than patients with
two kidneys because all stones would be coming from
only one organ. In addition, excretion of all minerals
via one kidney could, in theory, increase stone produc-
tion. Although urine volume from the one kidney should
equal that of the two kidneys in the past, habits remain-
ing constant, higher filtration rates per glomerulus could
increase local concentrations along the nephron [5–7].
Finally, progression of any renal disease is thought to
worsen as nephron number falls, so if stone formers in
general have even a modest tendency to lose renal func-
tion more rapidly than normal people, loss of a kidney
might accelerate further functional losses. Renal func-
tion, as estimated from measures of glomerular filtration
rate (GFR) normally declines with age at a rate of 0.8 to
1 mL/min/1.73 m2 per year [8–14]. Little is known about
age-related changes of GFR in patients with nephrolithi-
asis. This is especially true for patients who have lost a
kidney.
Stone formers who have lost a kidney, from stones,
complications of stone management, or unrelated dis-
eases such as renal cell carcinoma, constitute a potentially
instructive cohort. In principle, one can compare stone
relapse rates and rates of loss of renal function with age
among such patients to those of stone formers with two
kidneys, asking if either of the potential effects of kidney
loss—more frequent stones and more rapid loss of re-
nal function—were supported by observation. Over three
decades, we have measured stone formation rates, and
24-hour creatinine clearances in stone patients with one
and two kidneys, many of whom have been with us long
enough for serial measurements over considerable time.
We present here the effects of kidney loss on the course
of stone disease and creatinine clearance decline with
age. We present as well, the causes of kidney loss, mainly
as background and framework for the rest.
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METHODS
Patients
We reviewed all of our 3266 patients with nephrolithi-
asis. Among these, 115 had only one functioning kidney.
Every patient was evaluated on entry, prior to treatments
that could influence mineral metabolism, using a clinical
and laboratory protocol detailed elsewhere that has been
essentially unchanged since 1970. Among the patients,
only ten were of African American origin.
Evaluation
Three 24-hour urines were collected on an ambient
diet, with three corresponding blood samples drawn
at the conclusion of each collection between 7:00 and
9:00 a.m. in the postabsorptive state [15, 16]. All conven-
tional stone risk factors were measured, along with creati-
nine, used for a completeness of collection marker. Serum
creatinine was measured as well, to assess renal function,
and 24-hour creatinine clearance was calculated. At 6 to
8 weeks of treatment, we attempted to measure again,
in the same manner, but with a single blood and urine,
to assess treatment effects, as all of our patients were
evaluated with intent to treat. To the extent possible, we
obtained annual follow-up single urines and bloods. Our
experience is detailed elsewhere[17]. About 20% of pa-
tients drop out of laboratory surveillance at each follow-
up cycle. Single kidney patients have a lower dropout rate,
however.
All available radiographs of the kidneys are read at the
initial visit, and a complete history of stone formation and
stone treatments elicited. These data are coded into com-
puter records that have been used in many prior reports.
Stone analyses were obtained from old records or stan-
dard commercial sources as possible. Systemic causes of
stones were sought. During follow-up, new radiographs
are read, and surgical and medical stone treatments doc-
umented and recorded as available.
Cause of kidney loss
For the 115 patients we report here, each chart was re-
viewed to determine the apparent cause of kidney loss.
We chose the following criteria: (1) obstruction was ac-
cepted as cause if the x-ray films had shown its presence
or history tells of it, and no other more compelling cause
was recorded; (2) stone itself was taken as cause if ob-
struction, and all other causes, were excluded, and either
many stones were described in the kidney, or a staghorn
was present, or if the recorded clinical opinion at the time
was that stone burden was the apparent cause of kidney
loss; (3) surgery was taken as cause when a kidney was lost
at or shortly after a procedure that did not intend kidney
loss; (4) infection was taken as cause if clearly present, of
severe magnitude, and either the pathology of the organ
showed destruction by infection, or the clinical evaluation
at the time identified infection as the primary cause; (5)
cancer led to a small number of kidney removals; (6) age-
nesis or gross malformation was present in a few cases of
single kidney; and (7) when none of these was identified,
loss was classified as of cause unknown.
Some of these causes were present together (for exam-
ple, obstruction and infection, or a struvite staghorn of
large proportions). In these cases, we attempted as best
we could to identify the apparent main or primary cause.
For example, chronic obstruction led to cortical loss and
a dilated renal collecting system in some patients who, at
the end, presented with pyelonephritis. Usually we could
tell which was the main or antecedent condition. Because
clinical, these choices of cause will always have in them
some element of the uncertain and the subjective.
Analysis of data
Because we lack height measurements, we cannot ex-
press creatinine clearance per unit of surface area. Our
measurements are made in liters/24 hours. We have cho-
sen to present the data in these units. Because we hy-
pothesize that gender, nephrectomy or not, and age are
determinants of creatinine clearance, we have used analy-
sis of variance (ANOVA) and general linear models with
creatinine clearance as the dependent variable, gender
and nephrectomy status as factors, and age at time of
measurement as the covariate.
Evaluation of stone formation rates used negative-
binomial regression models with gender and nephrec-
tomy status as factors and either pretreatment interval
(time from first stone until entry into our program) or
time from entry into the program until last contact, as
measures of pre- and posttreatment exposures, respec-
tively. These models estimate differences in stone occur-
rence rates per year, allowing for substantial between-
patient heterogeneity. Since all patients had to have had
at least one stone prior to treatment, a truncated negative-
binomial regression model was employed for pretreat-
ment stone rates.
Stone analyses were available for subsets of patients.
When available, we classified each patient into type of
stone former in the following way: (1) struvite, if any stru-
vite was found in any stone; (2) cystine, if any cystine was
found in any stone or cystinuria was an established diag-
nosis; (3) uric acid, if uric acid was found in any stone and
struvite and cystine were never found; (4) calcium phos-
phate if any stone contained above 50% calcium phos-
phate and no stones contained struvite, cystine, or uric
acid; (5) calcium oxalate, if any stone contained above
50% calcium oxalate, and no stone contained struvite or
cystine or uric acid, or above 50% calcium phosphate.
All statistical tests, routine summary statistics, and data
tabulations employed conventional commercial software
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Table 1. Causes of kidney loss
Men Women All
Agenesis 2 1 3
Cancer 6 4 10
Infection 4 23 27
Obstruction 12 12 24
Stone 21 12 33
Surgery 6 3 9
Unknown 7 2 9
Total 58 57 115
Cell values in the table are not random: v 2 = 20.3, P = 0.002.
(Systat, Richmond, CA, USA; and Stata Corp. 2003, Stata
Statistical Software, Release 8.0., College Station, TX,
USA). Means are SEM unless otherwise noted.
RESULTS
How kidneys are lost
Among 3266 patients with nephrolithiasis (1097
women, 33.6%), 115 (57 women, 49.6%) (v 2 = 13.6, P =
0.0001, for over representation of women) had only one
intact functioning kidney (Nx). Thirty-three (16 women)
had a shrunken kidney judged to contribute no significant
renal function, 82 (41 women) had total nephrectomy. Of
all 115 patients, 28 had a shrunken kidney before our ini-
tial studies and 63 had their nephrectomy prior to our
initial studies. Over the three decades (by half-decade
for analysis) of our program (1970 to present), frequency
of kidney loss did not vary (v 2 = 8.5, df = 6, P = 0.20).
Stones and obstruction were the most common reason
for kidney loss in men (Table 1). For women, stones, ob-
struction, and particularly infection were most common.
These three reasons predominate over the other causes.
Hyperparathyroidism, renal tubular acidosis, and bowel
disease were no more frequent among those who lost kid-
neys than those who had not (results not shown). For con-
venience, we will use Nx to denote all 115 patients with
kidney loss, even though some lost kidney for reasons
other than surgery. Body weights did not differ between
Nx and no Nx among men (84 vs. 81 kg) or women (69 vs.
72 kg), P = NS for both comparisons.
Types of stones among patients who lost kidneys
Among the 1709 patients (525 women) for whom we
have stone analyses, the distribution of stone types be-
tween patients with and without Nx differed from chance
for both genders (Table 2). For men and women alike,
those with Nx had a superabundance of struvite stones,
compared to their same gender, two kidney counterparts
(v 2 = 29 and 18, P < 0.0001, men and women, respec-
tively, using 2 × 2 tables). Comparing the genders, stone
type differed for those with two kidneys, but not for those
with Nx. The most notable difference in patients with two
Table 2. Stone types in patients with and without loss of kidney tissue
Females Males
No Nx Nx No Nx Nx
(N = 496) (N = 29) (N = 1145) (N = 39)
CaOx 305 (58) 9 (31) 860 (75) 22 (56)
CaP 88 (17) 5 (17) 83 (7) 5 (13)
Cystine 22 (4) 3 (10) 23 (2) 1 (3)
Struvite 38 (7) 9 (31) 22 (2) 6 (15)
Uric acid 43 (8) 3 (10) 157 (14) 5 (13)
Column percent is in parentheses. Abbreviations are: CaOx, calcium oxalate;
CaP, calcium phosphate. For Nx vs. no, females and males, v 2 = 23, P < 0.0001;
no Nx, male vs. female, v 2 = 91, P < 0.0001; Nx, male vs. female, v 2 = 6.2, P =
0.184.
kidneys was the increased occurrence of calcium phos-
phate and struvite stones in women (limiting ourselves to
only no Nx patients, using a single 2 × 2 table, of gender
vs. calcium phosphate and struvite stones, or not, v 2 =
75, P < 0.0001; for Nx, by comparison, v 2 = 2.9, P =
0.09). Among Nx patients, the two genders did not differ
with respect to stone type. Males with Nx had the same
surplus of struvite and calcium phosphate stones as is gen-
erally found among women stone formers (males, Nx vs.
no Nx, for excess struvite and calcium phosphate stones
in Nx, v 2 = 15, P < 0.0001). In other words, patients with
Nx partake of or accentuate the female tendency toward
formation of stone types that appear to increase risk of
kidney loss.
Stone formation
Stone formation rates before treatment (Fig. 1A) form
a complex distribution over time (Fig. 1A). The contour
plot depicts two main populations of patients, those with
one stone (y axis) and a short interval between that stone
and entry (Fig. 1A, lower left quadrant), and another
more complex group centered at about 10 years of stone
disease, with an average of four stones (Fig. 1A, right mid-
dle portion). Because this is a kernel contour plot, regions
of high data density, which denote corresponding large
numbers of patients, appear as centers within the coiled
contours, as if looking down on a mountain range. One
can imagine a z axis showing numbers of patients that
correspond to various combinations of time and stone
number. The numbers on the graph itself denote levels
on such an axis, which is collapsed here. Nx patients are
shown as solid circles. The graph itself makes clear that es-
timates of simple average stone formation rates, or stones
per patient, can give little useful information. Of much
greater interest is to document differences in stone for-
mation rates between the genders and Nx groups. For this,
we employed negative binomial regression (see Methods
section). Male Nx patients had a pretreatment rate of
stone formation (6.5 stones/decade) that was lower than
male no Nx patients (23.5, P = 0.001). By comparison, fe-
male Nx patients had a pretreatment stone formation rate
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Fig. 1. Stone occurrence with time. (A) Numbers of stones (y axis) formed before entry increase with time from first stone to entry (x axis). Contour
lines show areas of greatest density for patients with two kidneys. Two kidney patients with one stone form a dense population centered at about
0.25 years. The other high-density populations consist of those with two, four, and eight stones at between 6 to 10 years. Patients with one kidney
(•) overlap the general pattern. (B) Stones during treatment follow-up form two dense populations, single stones at 7 and 12 years, and groups of
patients with two, three, and ten stones centered at about 10 years. The patients with one intact functioning kidney (Nx) behaved similarly.
(10.3) that was not significantly lower than female no Nx
patients (21.2, P = 0.70 for Nx vs. no Nx in females). Male
no Nx patients had higher pretreatment stone rates than
their female counterparts (P = 0.001), whereas male Nx
patients had pretreatment stone rates lower than female
Nx patients (P = 0.002).
After entry into treatment (Fig. 1B), few stones oc-
curred until after 5 to 6 years, and then an intense con-
centration of modest numbers of stones occurred about
10 years out. Using negative binomial regression, after en-
try, among those with at least 1 year of follow-up, rates of
stone formation per year were 61% lower in Nx patients
compared to no Nx patients (P = 0.012); rates were 29%
lower in women compared to men (P = 0.063). Stones
formed at the rates of 1.3 and 0.9 stones per decade in
male and female no Nx patients, respectively, compared
to rates of 0.5 and 0.4 stones per decade for male and fe-
male Nx patients. We could not detect an adverse effect
of Nx upon stone formation during treatment, meaning
that acceleration of stone relapse after kidney loss could
not be documented.
Alteration in urine stone risk factors by Nx
Pretreatment values for conventional stone risks
(Table 3) include those from no Nx patients, and those
from Nx patients whose kidneys were lost or removed
prior to entry into our program. Among men, serum
potassium, creatinine, and uric acid levels were higher
with Nx, serum CO2 and magnesium lower. Urine vol-
ume was higher, and urine calcium and citrate excretions
lower in the Nx group, and supersaturation values were
Table 3. Selected pretreatment laboratory data
Male Female
No Nx (2099) Nx (45) No Nx (1032) Nx (47)
Serum sodium 141 141 140 140
Serum potassium 4.16 4.42c 4.10 4.20
Serum uric acid 5.96 6.21 4.59 5.57c
Serum calcium 9.60 9.60 9.54 9.66
Serum creatinine 1.06 1.39c 0.87 1.13c
Serum CO2 27.6 24.0a 26.6 25.2
Serum magnesium 2.03 1.93a 1.98 2.00
Urine volume 1.68 1.95a 1.53 1.79
Urine citrate 513 368b 495 430
Urine calcium 235 189b 193 150b
Urine oxalate 43 48 34 37
Urine sodium 187 175 140 134
Urine potassium 63 61 49 48
Urine pH 5.99 5.90 6.15 6.02
SS CaOx 9.20 6.27c 8.84 6.80b
SS CaP 1.49 0.75c 1.47 0.82c
SS UA 1.29 0.98a 1.03 0.95
Abbreviations are: SS is supersaturation, CaOx, calcium oxalate, CaP, calcium
phosphate, UA, uric acid. All urine values are mg/day except sodium and
potassium (mEq/day) and volume (L/day); all serum values are mg/dL except
sodium and potassium (mEq/L), and CO2 (mmol/L).
a vs. no Nx, same gender P < 0.05; bP < 0.01; cP < 0.001.
reduced for all three stone forming salts. Among women,
serum creatinine and uric acid were higher with Nx, and
urine calcium and supersaturation with respect to cal-
cium oxalate and calcium phosphate were lower. These
differences are those one might expect from loss of kid-
ney function [18]. The present study was not intended to
explore their mechanisms in detail. Of importance, they
do not point to any metabolic factors that would lead to
either kidney loss, or more stones with kidney loss.
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Table 4. Unadjusted creatinine clearances
Male Female
C (2079) Nx (58) Nxb (45) C (994) Nx (56) Nxb (45)
Pre 178 ± 40 140 ± 49c 133 ± 50c 141 ± 40 115 ± 37c 112 ± 38c
Last 171 ± 45 120 ± 42c 121 ± 45c 138 ± 42 115 ± 36c 117 ± 36b
Del −9 ± 32d −19 ± 30a,d −10 ± 22d −6 ± 33d −11 ± 26a,d −6 ± 25
Age ent 44 ± 12 53 ± 12c 53 ± 13c 42 ± 14 47 ± 15b 50 ± 14c
Age last 49 ± 13 61 ± 13c 59 ± 14c 46 ± 14 55 ± 14c 57 ± 15c
Yr FU 4 ± 6 8 ± 7c 6 ± 7 4 ± 6 8 ± 8c 7 ± 7b
Abbreviations are: Pre, last, del refer to creatinine clearance (L/day) at entry, last measurement, and change between first and last measurement, respectively. Age
ent and last refer to age at entry and last measurement, respectively. Yr FU refers to years between the initial and last measurement. C refers to control NX refers to all
patients with kidney loss and Nxb refers to patients with kidney loss before first urine measurements.
avs. controls, same gender, P < 0.05; bP < 0.01; cP < 0.001; d vs. 0, P < 0.01; all values are mean ± SD.
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Fig. 2. Creatinine clearance changes with age. Initial creatinine clearance (y axis) for patients with two kidneys (A) (background of tiny points)
was stable with age (x axis) up to approximately 45 years, as illustrated by the density weighted least squares lines of best fit (solid line, male; broad
dashed line, female), and as documented by our regression analysis (see Results section). Male patients with one kidney ( ) had a somewhat higher
slope of clearance loss with age, mainly because of a scattering of higher values at younger ages. Females with one kidney (•) lost clearance in a
manner similar to that of two kidney patients. The pattern for last creatinine clearance (C) (same symbols and lines) was similar, except the higher
slope of single kidney males is not evident. Change in clearance between first and last measurement (B) centered around zero(dashed horizontal
line), and began a decline for both genders at about 5 to 6 years. Data for one intact functioning kidney (Nx) patients followed this general pattern.
Creatinine clearance by age and gender with
and without Nx
As expected, patients with Nx had lower values of cre-
atinine clearance both at their initial evaluation and their
final measurement (Table 4), compared to same-gender
patients without loss. Patients with Nx were older than
those without (Table 4). Change of clearance between
initial and final evaluation among all men was higher in
those with Nx (Table 4), but if we include only patients
whose renal loss occurred before their initial evaluation
(NxB), this difference disappears. Presumably it arose
because of the additional loss of function from Nx after
entry. Change in clearance differed from 0 in all groups
except for females with Nx before entry into our pro-
gram. Overall, clearance fell, but we could not document
effects of Nx to increase clearance loss.
Within the population, initial and final creatinine clear-
ance fell with age in all four groups (Fig. 2A and C), but
the fall in clearance seems to begin at about 45 years
of age, as judged from the slope of the density weighted
least square line fit. The same pattern holds for the
last clearance (Fig. 2C) as for the initial measurements.
Change in clearance between entry and last measure-
ment (Fig. 2B) remains close to 0 (dashed horizontal line)
until about 7 to 8 years, whereupon all groups show a
decline.
In order to quantify the visual impression of a plateau
followed by a fall, we calculated the regressions of ini-
tial creatinine clearance on age, by gender, and Nx status.
Considering initial clearance, in patients with loss of kid-
ney before entering our program, among men <45 years
old, the regression slopes were not significant, whereas
they were significant age >45: 0.18 (−0.17 to 0.52) vs.
−2.48 (−6.36 to 1.41) no Nx vs. Nx, under 45 years old;
and −2.03 (−2.32 to −1.73) vs. −3.19 (−4.80 to −1.54)
no Nx vs. Nx, over 45 years old (95% CI); P values for
>45 years <0.001. Among women, the same: 0.34 (−0.052
to 0.740) vs. 1.26 (−1.07 to 3.58) and −1.76 (−2.26 to
−1.25) vs. −2.39 (−3.87 to −0.90), no Nx vs. Nx, un-
der 45 years and over 45 years, respectively; P values for
>45 years both <0.001). In other words, the impression
of stability of clearance before age 45 years is confirmed,
as is the presence of a significant downward slope after
age 45 years.
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Creatinine clearance loss adjusted for age and
gender (cross-sectional study)
Given that both initial and last clearances (Fig. 2) de-
pend on age, and that ages differ between patients with
and without renal loss (Table 4), we asked if initial and
last clearance, adjusted for age at the time of the measure-
ment, differed with Nx, and by gender. Considering the
genders separately, and including only patients with Nx
before entry, in a general linear model with initial clear-
ance as dependent, age at entry was highly significant as
a covariate for females (P < 0.001), and the interaction
term of Nx and age at entry was not significant (P = 0.49).
For men, the interaction term of Nx and age at entry was
highly significant (P = 0.003). This means that the slopes
of clearance on age were not homogeneous for Nx and no
Nx males, a finding consistent with a comparison of sim-
ple regressions for the groups: −0.99 (−1.12 to −0.86) vs.
−2.31 (−3.26 to −1.36) no Nx vs. Nx for males, and −0.74
(−0.94 to −0.59) vs. −1.00 (−1.74 to −0.26) no Nx vs.
Nx for females; all regressions are significant, P < 0.001.
The lower bound of the 95% CI for no Nx males does
not reach the upper bound of the 95% CI for Nx males,
meaning that the negative slope for Nx males is greater
than that for no Nx males. By contrast, the CI values over-
lap for females. Age-adjusted mean values for creatinine
clearance were not different from unadjusted for the no
Nx patients shown in Table 4. For the Nx patients, values
did differ (119 ± 6 (SEM) and 152 ± 7 for females and
males, respectively. Both values differ from non-Nx, P <
0.001.
If we restrict the analysis to only people >age 45 years
at entry, the interaction of clearance loss with age is no
longer affected by Nx status (data not shown). This fact
agrees with the overlap of simple regression coefficients
shown in the preceding section, for patients over 45 years,
and suggests that the effects of Nx on loss of renal function
may be especially prominent at younger ages in men. In
the same model, considering all patients, with last creati-
nine clearance as dependent, and age at last measurement
as covariate, neither the interaction terms nor effects of
Nx were significant for either gender, although the re-
gression of clearance on age was highly significant (P <
0.001, both genders; results not shown). This finding is
compatible with those for people above age 45 years at
entry, because patients were older at their last follow-up
(Table 4). Overall, it appears that men <age 45 years with
Nx may be at a higher risk for loss of clearance than other
patients; the present data do not permit further analysis
of this point.
Change in creatinine clearance with age and Nx
(longitudinal study)
Finally, considering all patients, change in clearance
from first to last measurements was highly dependent on
years of follow-up (P < 0.001, both genders), but nei-
ther Nx, nor the interaction of Nx with years of follow-up
was significant. In a model that contained both age at last
measurement and years of follow-up, only the latter was a
significant covariate. These results were unchanged when
the patients were restricted to those older than 45 years
at entry, in whom loss of function with age would be ex-
pected to be significant. Change in creatinine clearance
was also highly dependent upon the pretreatment clear-
ance. In both genders, with change in clearance as depen-
dent, years of follow-up, age at entry, and pretreatment
clearance were significant covariates (P < 0.001, for all
three). In this model, Nx was significant as a factor for
men but not women (adjusted least square means were
−9 vs. −18 L, and −6 vs. −7 L per 24-hour per year,
males and females, respectively, no Nx vs. Nx, P = 0.03
for males, and 0.83 for females). Overall, men and women
differ. Once adjusted for initial clearance as well as age
and time of follow-up, males seem to have a higher loss
of function with Nx than with no Nx, whereas females do
not.
Loss of initial creatinine clearance with age as
a fraction of baseline (cross-sectional estimates)
Quite apart from our contrasts of Nx and no Nx, we
would like to compare our patients, in both groups, to
those studied elsewhere, so as to ask not only if Nx in-
creases loss of function among stone formers, but also if
stone formers themselves, with or without Nx, lose clear-
ance with age at the same rate as people without stones.
Prior studies have expressed clearances per 1.73 m2 of
body surface, which we cannot do, lacking height mea-
surements. Some studies have used other markers of GFR
apart from creatinine. Measurement of serum creatinine
varies in technique from study to study. Therefore, we
have chosen to express creatinine clearance for patients
older than 45 years as a fraction of clearance among same-
gender younger patients <45 years to compare fractional
losses among our patients to fractional losses we can cal-
culate from prior data sets. For our patients, we took ad-
vantage of the stability of clearance before age 45 years
to give a stable initial value. For other studies (Table 5),
we used clearances for the youngest 10-year cohort. Fi-
nally, by way of nomenclature, we refer to our clearances
as creatinine clearances, which is correct. For the other
studies (Table 5), we use GFR as a generic name to cover
the range of techniques and markers employed.
In order to quantify change in clearance as a fraction
of a stable baseline, we first calculated plateau values,
by gender, for patients younger than 45 years and older
than 18 years in those with or without Nx. We chose
only those with Nx before our initial evaluation. This is
the exact region in which we have already documented
a lack of a significant regression of clearance on age.
For men, plateau clearance values did not differ with Nx
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Table 5. Regression slopes of glomerular filtration rate (GFR) on age
Male Female
Slope Lower 95% Upper 95% Slope Lower 95% Upper 95% CI
Rowe et al −0.006 −0.008 −0.005 — — —
Kampmann et al −0.009 −0.01 −0.008 −0.009 −0.011 −0.008
Wesson (Baylis and Schmidt) −0.008 −0.01 −0.006 −0.006 −0.008 −0.004
Current −0.009 −0.014 −0.004 −0.009 −0.014 −0.005
Current > 45 −0.011 −0.012 −0.009 −0.012 −0.015 −0.008
Current NX > 45 −0.019 −0.029 −0.01 −0.019 −0.03 −0.007
Slope is the regression coefficient for simple linear regression of GFR on age; lower and upper are the boundaries of the 95% CI for the slopes. Current refers to
our own data; current > 45 refers to our data for patients above age 45 years at entry into our program. All values are calculated for the ratio of GFR at a given age
to the GFR for the youngest age decade within the study; for current >45 values are individual ratios of creatinine clearance at entry to same gender corresponding
creatinine clearances for patients < 45. Kampmann et al [19], Wesson [11], and Rowe et al [12], refer to the three published comparison studies; Baylis and Schmidt in
fact published the Wesson data in an accessible form.
(164 ± 47 L/day vs. 188 ± 39 L/day, Nx vs. no Nx, 10 vs.
1096 patients, P = 0.16) but did for women, perhaps be-
cause of larger numbers of females with Nx (123 ± 28 L/
day vs. 149 ± 35 L/day, 17 vs. 588 patients, Nx vs. no Nx,
P = 0.002). As expected, plateau values differed by
gender within the Nx and no Nx groups (P < 0.001
and <0.026, for gender difference, no Nx and Nx,
respectively).
Given these plateau values, we calculated for each pa-
tient over 45 years old, those old enough to lose clearance
reliably with age, the ratio of their initial clearance mean
value to the corresponding gender and Nx group plateau
value. We used only patients with Nx prior to entering
our program. Using simple linear regression of this ratio
on age, by gender, and Nx status, values for the regression
slope did not differ between genders, or by Nx: −0.011
(−0.012 to −0.009) vs. −0.019 (−0.029 to −0.010), and
−0.012 (−0.015 to −0.008) vs. −0.019 (−0.03 to −0.007),
no Nx vs. Nx, males and females, respectively, 95% CI
in parentheses. All regressions are significant P < 0.01.
Given the overlap of 95% CI ranges, Nx and no Nx did
not differ.
In order to analyze effects of age more specifically than
by mere comparison of regression coefficients, we chose
to analyze the ratio with age for the two genders sep-
arately, among these same groups. For men, an initial
general linear model with the ratio as dependent, age
as covariate, and Nx as factor showed a significant in-
teraction between Nx and the relationship of the ratio
to age (F = 4.7, P = 0.029). Therefore the slopes of the
ratio on age are not homogeneous. The differences in
individual simple linear regression slopes noted above
are therefore, in all probability, reflective of a true differ-
ence in slope despite overlapping 95% CI. For women,
the same general linear model shows no significant in-
teraction term, nor effects of Nx, although, as for men,
the ratio is highly dependent on age, as expected (re-
sults not shown). This may reflect the very wide con-
fidence interval for the simple linear regression noted
above. Altogether, loss of a kidney appears to increase
fractional rate of loss of clearance in men, to a detectible
extent.
Final creatinine clearance loss analyzed in relation
to age (cross-sectional study)
In order to confirm these findings, we created a similar
ratio for the last clearance obtained for each patient, by
dividing the last clearance in patients over 45 years old by
the plateau clearance values for corresponding patients
<45 years of age, with or without Nx. However, unlike
the analysis of pre treatment clearances, which was lim-
ited to the ratio among patients who had lost their kid-
neys prior to entry, we included here the ratio for all pa-
tients, because by the time of the last measurement all
who would lose kidney tissue had done so. Simple linear
regressions,−0.012 (−0.013 to−0.010) vs.−0.012 (−0.020
to −0.003) and −0.015 (−0.018 to 0.012) vs. −0.019 (−0.03
to −0.007), no Nx vs Nx, males and females, respectively,
suggest no effects of Nx or gender. Using a general linear
model with the ratio as dependent, age at last evaluation
as covariate, and Nx as factor, the interaction terms of Nx
with age were not significant for either gender, nor were
the P values for the effects of Nx within gender. In other
words, for this measurement, there is no effect of gender
or Nx on the loss of function with age.
Fractional change in creatinine clearance analyzed
in relation to age (longitudinal studies)
We formed the ratio of change in clearance between the
initial and last measurements for each person, divided by
the length of the interval between them, and divided that
variable (liter/day/year) by the initial plateau values used
to form the other ratios, to give fractional change in clear-
ance per year. Values of this variable were not different
with kidney loss within gender (−0.035 vs. −0.110, and
0.073 vs. 0.006, no loss vs. loss, males and females, all P
values NS). Although different even in direction, values
for gender did not differ within the Nx classes. In other
words, fractional loss of function within the rather short
time periods of our observation (Table 4) was unaffected
by Nx.
Comparison to prior studies
We have found three studies [11, 12, 19] among many
others [14, 20–25] that can be used for comparisons. The
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Fig. 3. Comparison of glomerular filtration
rate (GFR) loss with age to prior studies.
Among males (A), creatinine clearance (CCr)
expressed by decade (x axis) as a fraction of
creatinine clearance among patients in the
youngest decade (y axis) showed a stable
plateau up to the fifth decade for our patients
(). Patients in the study of Rowe et al [12]
( ), Kampmann et al [19] ( ), and Wesson
[11] (•) lost renal function in a progressive
manner over time. After the fifth decade, our
no Nx patients (those without one intact func-
tioning kidney) shown here lost function at
an increasing rate, whereas the other groups
lost function a stable rate. Among women (B),
the same pattern was evident, except that the
Rowe study did not include values for women.
three share in common large data sets, above 100 subjects,
and sufficient information is presented so that we can cal-
culate clearances to the common metric of our ratios for a
direct comparison. For each of the three published stud-
ies, we calculated the mean clearance for each decade be-
tween 20 and 90 years of age. We expressed clearance by
gender for each decade as a ratio of the clearance in that
decade to the clearance in the youngest decade. Although
some studies presented decades from their beginning and
others from their mid-points, we present all data as the
mid-point of the presented range. The data set of Wesson
was taken from the paper by Baylis and Schmidt [11]. The
original data are published in Physiology of the Human
Kidney, Grune and Stratton, New York, NY, 1969, pages
96–108.
Among men (Fig. 3A), our own patients display a pat-
tern of stability of renal function to age 40 years, with
an accelerating rate of decline thereafter. By contrast,
the other three groups show a pattern of steady decline.
Among women (Fig. 3B), much the same is evident. These
variations in the pattern of creatinine clearance decline
with age make direct comparisons of linear slopes some-
what difficult to interpret. Among men, in a general linear
model with the ratio as dependent and age as a covari-
ate, the interaction term of age and data set was highly
significant (P = 0.002). Among women, age was an
equally significant covariate, but the interaction term was
insignificant (P = 0.96). In other words, the males in our
four available studies differ in the rate of GFR loss with
age, even with the limitation of simple linear approxima-
tions to the loss function.
Although we do not have access to the complete data
sets, we can calculate regression slopes from the six or
seven mid-decade points for each study, and compare
them to each other and to our regression slopes that we
calculate both from the restricted decade plot and our
full data set (Table 5). Rowe et al [12] and Kampmann
et al [19] do not overlap in their 95% CI ranges, which
accounts for the significant heterogeneity of slopes for
males. Our 95% CI range for men overlaps all of the
other studies. Although the other results are consistent
with a linear decline in GFR with age, our findings suggest
a nonlinear decline, with rates accelerating with age. If we
consider only males >45 years, the range in which crea-
tinine clearance does fall with age among our patients,
our regression slope exceeds that of Rowe et al [12], al-
though it does overlap with the other two studies. Among
women, all 95% CI ranges overlap. Finally, our male and
female Nx patients have steeper slope values than any
other groups, but their 95% CI range abuts against that of
the Kampmann et al [19] and Wesson series. For females,
overlap is complete. Overall, our patients lose creatinine
clearance with age in a manner that is not completely
comparable to that of other published studies, and males
in particular, when older than 45 years, may well be losing
GFR at a higher rate than normal. For those with Nx, we
suggest the case is uncertain, and that with larger num-
bers of patients, a higher rate of GFR loss may well be
demonstrated.
DISCUSSION
Kidney loss is not common among stone formers (3.5%
in our clinic, a referral practice, over 30 years), and for
those who lose a kidney the outcome does not seem overly
dire. That females have approximately a twofold risk for
kidney loss above that of males has not been previously
documented. Reasons for loss are not unexpected: stone
mass, infection, obstruction, and diverse illnesses. For ex-
ample, we and others have documented significant rates
of kidney loss in patients with struvite or cystine stones
[26, 27]. In terms of stone disease itself, and renal func-
tion, we could not establish excess peril for single kidney
patients. Altogether, our results do not support the idea
that stone formers should not donate kidneys, provided
they would be otherwise acceptable as donors to a trans-
plant program.
We have no reason to believe that stone formation it-
self is accelerated by kidney loss. In addition, we have no
support for the idea that patients with the highest stone
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formation rates are those who are most likely to lose a
kidney. Those with one kidney had somewhat lower pre-
treatment stone formation rates than those with two kid-
neys. Perhaps this reflects formation of a few large stones
that may have led to kidney loss. We cannot recover the
detailed mechanisms. During treatment, stones recurred
at lower rates in patients with one versus two kidneys.
New stones occurred in 16 of our 115 patients (14%)
over the approximately 6 to 8 years of average follow-
up (Table 4), less than the 30% recurrence over 0.5 to
6.1 years described among Nx patients by Lee, et al [28].
Overall, loss of a kidney does not worsen stone disease.
Given that patients with one kidney are more likely to
seek care than those with two, their lower rates of stone
formation are most likely biased upward, meaning that
the true difference might be even greater than what we
found.
Like all of us, stone formers lose renal function regu-
larly as they age, the two genders more or less in the same
manner. Losing a kidney reduced age adjusted clearance,
by about 15% in our study. Others[29, 30] have noted a
drop of about 30% in uninephrectomized patients, but
these were mainly longitudinal studies of individuals,
whereas our study was mainly cross-sectional. In addi-
tion, past studies did not adjust for age differences, as we
have. Our own longitudinal data spanned only a 10-year
period, and did not compare pre-Nx to post-Nx for indi-
viduals. Among men, we were able to detect an increased
rate of clearance loss with age after Nx, but only when
we considered men of all ages between 18 and 80 years.
Accelerated loss of creatinine clearance was not detected
when we considered only men above age 45 years. This
suggests that younger men may be losing clearance at
a particularly high rate after kidney loss, but we cannot
prove this conjecture because of the cross-sectional na-
ture of our data.
When we considered the ratio of measured clearance
among men above age 45 years to the average clearance
of men under 45 years—whose clearance was not falling
with age—we could detect a higher loss rate among men
with Nx. We detected this using a general linear model
that disclosed a lack of homogeneity of slopes of crea-
tinine clearance on age for Nx vs. no Nx in men. This
difference may well reflect our correction of clearances
in older men by the plateau values among young men.
We cannot explore this issue further with the informa-
tion available here. Women display no effect whatever of
Nx on rate of loss of kidney function.
In this clinical study, we have creatinine clearance, not
true GFR, and this clearance, being a mix of filtration and
tubule secretion, is prone to overestimate GFR. We have
no knowledge of whether or how stone formation could
affect the creatinine secretion. In general, the secretion
artifact masks falls in true GFR, so that what we see with
age by way of loss is probably an underestimate of the true
loss. The studies we used for comparison employed cre-
atinine clearance [12, 19] and inulin clearance[11]. This
latter (Wesson et al, Table 5) does not depart remarkably
from the other studies, suggesting that our use of ratios
can remove significant variance arising from technique.
Conventional urine stone risk factors were affected by
kidney loss, as one might expect. Among both genders,
urine calcium was lower with one kidney, as was calcium
oxalate and calcium phosphate supersaturation. Among
men, we detected a slight rise in serum potassium and
fall in serum bicarbonate suggesting loss of renal acidi-
fication, and in both genders we found increased serum
creatinine as already mentioned.
Altogether, loss of one kidney, although regrettable,
does not seem to greatly affect prognosis for renal func-
tion or stone disease. Stone rates are not increased ei-
ther before treatment or during treatment. If we began
this work with a question about the possible dangers of
stone patients donating kidneys, this work would seem to
point to a not unfavorable conclusion concerning stone
formation itself. By itself, our work cannot be taken as
sufficient, being merely retrospective observation. How-
ever, it does suggest that a formal trial of stone formers
as donors might not be unfeasible on grounds of safety.
On the other hand, the unexpected finding of an accel-
erated rate of loss of creatinine clearance among stone
formers in general as compared to some normal sub-
jects suggests that this disease is indeed not merely that
of stones themselves but also involves the kidneys. It
is true that obstruction episodes and surgery may ac-
count for the increase of loss of clearance, but the al-
ternative may also be true. Stone disease involves the
kidney tissues in some ways other than those associated
with sporadic stone passage episodes [31]. The stones
that led to kidney loss were in general not the com-
mon small calcium oxalate stones, but frequently stru-
vite stones, from infection, or stones that had produced
a large mass effect in the kidney. As well, if we consider
only the large-scale clinical significance of GFR loss, no
patients in our series developed end-stage renal disease
(ESRD), and our average values by age 75 years (Fig. 3)
are in line with corresponding values from published
studies.
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